As of Aug 28
| -0.80 / -1.60%|
The 26 analysts offering 12-month price forecasts for Sanofi have a median target of 57.40, with a high estimate of 66.63 and a low estimate of 44.77. The median estimate represents a +16.48% increase from the last price of 49.28.
The current consensus among 28 polled investment analysts is to Buy stock in Sanofi. This rating has held steady since August, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.